[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years].
Children aged 3 to 14 were immunized with live recombinant influenza A vaccine; about 120,000 children were followed up for 6 months. Analysis of the morbidity (excepting ARVI and influenza) of the immunized and control groups permitted a conclusion about the safety of the preparation. The protective index of vaccine efficacy during influenza epidemic caused by A/Taiwan/1/86(H1N1) virus was 1.3 to 1.42. Live recombinant influenza vaccine is recommended for public health to be used for protection of children aged 3 to 14 from influenza.
Rudenko
L G
LG
Vasil'eva
R I
RI
Ismagulov
A T
AT
Karagodina
V I
VI
Slepushkin
A N
AN
Doroshenko
E M
EM
Gudkova
E M
EM
Utegulova
A Kh
AKh
Grigor'eva
E P
EP
Burtseva
E I
EI
Beliaev
A L
AL
Lonskaia
N I
NI
Drinevskiĭ
V P
VP
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006801:Humans; D009980:Influenza A virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000592:standards*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000592:standards
D007252:Influenza Vaccines; D014614:Vaccines, Synthetic
Profilakticheskaia éffektivnost' zhivoĭ grippoznoĭ rekombinantnoĭ vaktsiny tipa A pri immunizatsii deteĭ 3-14 let.